Parallax Volatility Advisers, L.P. Bridge Bio Pharma, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$24.02 - $43.89 $6.37 Million - $11.6 Million
265,300 Added 604.33%
309,200 $12.5 Million
Q3 2023

Nov 14, 2023
BUY
$16.89 - $35.01 $489,810 - $1.02 Million
29,000 Added 194.63%
43,900 $1.16 Million
Q2 2023

Aug 14, 2023
BUY
$13.29 - $18.01 $198,021 - $268,349
14,900 New
14,900 $256,000
Q1 2021

May 14, 2021
BUY
$55.47 - $72.35 $554,700 - $723,500
10,000 New
10,000 $616,000

Others Institutions Holding BBIO

# of Institutions
290
Shares Held
170M
Call Options Held
10.4M
Put Options Held
2.37M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email